Medtech remit in Brazil's disease monitoring centre
This article was originally published in Clinica
Brazil has set up a new department focused on collecting, analysing and broadcasting information on disease outbreaks and the evolution of certain healthcare programmes - but the Centre for Strategic Healthcare Vigilance Information (CIEVS) will also play a part in advising the national vigilance service (SVS) regarding the technical needs of the system, such as ensuring adequate laboratory capacity.
You may also be interested in...
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.
Duo will study up to four novel preclinical targets identified by Sitryx that may lead to potential new drugs for autoimmune diseases, which Lilly would then commercialize.